{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:01:19Z","timestamp":1789678879813,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":2986,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Janssen-Cilag Medical Affairs EMEA, a division of Janssen Pharmaceutica NV, Beerse, Belgium"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1093\/bja\/aep253","type":"journal-article","created":{"date-parts":[[2009,9,7]],"date-time":"2009-09-07T20:25:02Z","timestamp":1252355102000},"page":"576-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain"],"prefix":"10.1016","volume":"103","author":[{"given":"J.","family":"Devulder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Richarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wiggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aep253_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bmj.322.7295.1154","article-title":"Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain","volume":"322","author":"Allan","year":"2001","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aep253_bib2","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1097\/01.brs.0000186860.23078.a8","article-title":"Transdermal fentanyl versus sustained release oral morphine in strong-opioid na\u00efve patients with chronic low back pain","volume":"30","author":"Allan","year":"2005","journal-title":"Spine"},{"key":"10.1093\/bja\/aep253_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(94)00262-D","article-title":"Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial","volume":"62","author":"Arkinstall","year":"1995","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpainsymman.2003.11.006","article-title":"Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee","volume":"28","author":"Babul","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aep253_bib5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep253_bib6","first-page":"296","article-title":"Consensus panel recommendations for the assessment and management of breakthrough pain. Part 1: Assessment","volume":"30","author":"Bennett","year":"2005","journal-title":"Pharm Ther"},{"key":"10.1093\/bja\/aep253_bib7","first-page":"354","article-title":"Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2: Management","volume":"30","author":"Bennett","year":"2005","journal-title":"Pharm Ther"},{"key":"10.1093\/bja\/aep253_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5055\/jom.2007.0046","article-title":"Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics","volume":"3","author":"Bennett","year":"2007","journal-title":"J Opioid Manag"},{"key":"10.1093\/bja\/aep253_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2002-34640","article-title":"Fentanyl-TTS in the treatment of pain caused by rheumatoid arthritis","volume":"27","author":"Berliner","year":"2002","journal-title":"Akt Rheumatol"},{"key":"10.1093\/bja\/aep253_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","article-title":"Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial","volume":"104","author":"Boureau","year":"2003","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib11","first-page":"862","article-title":"Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial","volume":"26","author":"Caldwell","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1093\/bja\/aep253_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0885-3924(02)00383-4","article-title":"Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial","volume":"23","author":"Caldwell","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aep253_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1191\/0269216304pm890oa","article-title":"Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey","volume":"18","author":"Caraceni","year":"2004","journal-title":"Palliat Med"},{"key":"10.1093\/bja\/aep253_bib14","first-page":"129","article-title":"Effectiveness, tolerability and quality of life in the management of chronic pain unrelated to cancer with sustained-release tramadol administered in a single daily dose","volume":"11","author":"Casals","year":"2004","journal-title":"Rev Soc Esp Dolor"},{"key":"10.1093\/bja\/aep253_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6963-5-3","article-title":"A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity","volume":"5","author":"Chelminski","year":"2005","journal-title":"BMC Health Serv Res"},{"key":"10.1093\/bja\/aep253_bib16","first-page":"222","article-title":"Advantage of controlled-release tramadol in treatment of chronic musculoskeletal pain","volume":"9","author":"Chen","year":"2005","journal-title":"Chin J Clin Rehabil"},{"key":"10.1093\/bja\/aep253_bib17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1185\/030079904X2114","article-title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain","volume":"20","author":"Clark","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/bja\/aep253_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0885-3924(98)00070-0","article-title":"Prolonged treatment with transdermal fentanyl in neuropathic pain","volume":"16","author":"Dellemijn","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aep253_bib19","first-page":"29","article-title":"Tilidine\/naloxone slow release for the long-term treatment of chronic pain patients","volume":"120","author":"Fl\u00f6ter","year":"2002","journal-title":"Fortschritte der Medizin"},{"key":"10.1093\/bja\/aep253_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1191\/0269216306pm1099oa","article-title":"Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study","volume":"20","author":"Fredheim","year":"2006","journal-title":"Palliat Med"},{"key":"10.1093\/bja\/aep253_bib21","first-page":"310","article-title":"Controlled release oxycodone for the treatment of chronic pain","volume":"54","author":"Gaertner","year":"2003","journal-title":"Med Welt"},{"key":"10.1093\/bja\/aep253_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"key":"10.1093\/bja\/aep253_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0885-3924(97)00352-7","article-title":"Outcome of chronic opioid therapy for non-cancer pain","volume":"15","author":"Haythornthwaite","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aep253_bib24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1399-6576.2006.01154.x","article-title":"Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study","volume":"50","author":"H\u00f8jsted","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1093\/bja\/aep253_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1093\/bja\/aep253_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpain.2004.11.009","article-title":"Opioid tolerance and dependence\u2014do they matter?","volume":"9","author":"Jage","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1093\/bja\/aep253_bib27","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1097\/00007632-199812010-00014","article-title":"Opioid therapy for chronic noncancer back pain. A randomized prospective study","volume":"23","author":"Jamison","year":"1998","journal-title":"Spine"},{"key":"10.1093\/bja\/aep253_bib28","first-page":"1091","article-title":"Opioids for managing chronic non-malignant pain: safe and effective prescribing","volume":"52","author":"Kahan","year":"2006","journal-title":"Can Fam Physician"},{"key":"10.1093\/bja\/aep253_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1185\/030079905X46377","article-title":"An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system","volume":"21","author":"Kosinski","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/bja\/aep253_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.21884","article-title":"Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial","volume":"54","author":"Langford","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1093\/bja\/aep253_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.mjt.0000160935.62883.ff","article-title":"Sublingual buprenorphine is effective in the treatment of chronic pain syndrome","volume":"12","author":"Malinoff","year":"2005","journal-title":"Am J Ther"},{"key":"10.1093\/bja\/aep253_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2710.2004.00624.x","article-title":"Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain","volume":"30","author":"Malonne","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1093\/bja\/aep253_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.ajp.0000146215.86038.38","article-title":"Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial","volume":"21","author":"Markenson","year":"2005","journal-title":"Clin J Pain"},{"key":"10.1093\/bja\/aep253_bib35","first-page":"205","article-title":"Economic evaluation of controlled-release oxycodone vs. oxycodone\u2013acetaminophen for osteoarthritis pain of the hip or knee","volume":"12","author":"Marshall","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1093\/bja\/aep253_bib36","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1526-4637.2006.00270.x","article-title":"The treatment of breakthrough pain","volume":"8","author":"McCarberg","year":"2007","journal-title":"Pain Med"},{"key":"10.1093\/bja\/aep253_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.mjt.0000139442.65914.f9","article-title":"Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study","volume":"12","author":"McIlwain","year":"2005","journal-title":"Am J Ther"},{"key":"10.1093\/bja\/aep253_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1526-4637.2004.04005.x","article-title":"The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions","volume":"5","author":"Menefee","year":"2004","journal-title":"Pain Med"},{"key":"10.1093\/bja\/aep253_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1054\/jpai.2001.25352","article-title":"Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain","volume":"2","author":"Milligan","year":"2001","journal-title":"J Pain"},{"key":"10.1093\/bja\/aep253_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00044011-200424090-00005","article-title":"Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: a randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee","volume":"24","author":"Mongin","year":"2004","journal-title":"Clin Drug Investig"},{"key":"10.1093\/bja\/aep253_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(96)90339-6","article-title":"Randomised trial of oral morphine for chronic non-cancer pain","volume":"347","author":"Moulin","year":"1996","journal-title":"Lancet"},{"key":"10.1093\/bja\/aep253_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clinthera.2005.04.007","article-title":"Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study","volume":"27","author":"Muriel","year":"2005","journal-title":"Clin Ther"},{"key":"10.1093\/bja\/aep253_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1526-5900(03)00632-1","article-title":"Long-term management of noncancer pain with transdermal therapeutic system-fentanyl","volume":"4","author":"Mystakidou","year":"2003","journal-title":"J Pain"},{"key":"10.1093\/bja\/aep253_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1185\/030079906X89784","article-title":"Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules","volume":"22","author":"Nicholson","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/bja\/aep253_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/IJGC:27:3:235","article-title":"Opioid treatment of painful chronic pancreatitis","volume":"27","author":"Niemann","year":"2000","journal-title":"Int J Pancreatol"},{"key":"10.1093\/bja\/aep253_bib46","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1185\/030079906X115540","article-title":"A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain","volume":"22","author":"Otis","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/bja\/aep253_bib47","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1185\/030079904X14120","article-title":"Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control","volume":"20","author":"Pavelka","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/bja\/aep253_bib48","first-page":"764","article-title":"Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee","volume":"27","author":"Peloso","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1093\/bja\/aep253_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jpain.2006.02.003","article-title":"Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain","volume":"7","author":"Portenoy","year":"2006","journal-title":"J Pain"},{"key":"10.1093\/bja\/aep253_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/030079906X162818","article-title":"Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/bja\/aep253_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(99)00006-8","article-title":"Breakthrough pain: characteristics and impact in patients with cancer pain","volume":"81","author":"Portenoy","year":"1999","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1191\/026921600671594561","article-title":"Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine","volume":"14","author":"Radbruch","year":"2000","journal-title":"Palliat Med"},{"key":"10.1093\/bja\/aep253_bib54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1093\/bja\/aep253_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00296-002-0217-8","article-title":"Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis","volume":"22","author":"Ringe","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1093\/bja\/aep253_bib56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.160.6.853","article-title":"Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation","volume":"160","author":"Roth","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1093\/bja\/aep253_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1155\/2003\/592846","article-title":"Evaluation of dosing guidelines for use of controlled-release codeine in chronic noncancer pain","volume":"8","author":"Russell","year":"2003","journal-title":"Pain Res Manag"},{"key":"10.1093\/bja\/aep253_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00002508-199906000-00011","article-title":"Long-term opioid analgesic therapy for severe refractory lumbar spine pain","volume":"15","author":"Schofferman","year":"1999","journal-title":"Clin J Pain"},{"key":"10.1093\/bja\/aep253_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5055\/jom.2006.0051","article-title":"Breakthrough pain in opioid-treated patients with neuropathic pain","volume":"2","author":"Simon","year":"2006","journal-title":"J Opioid Manag"},{"key":"10.1093\/bja\/aep253_bib60","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clinthera.2007.04.007","article-title":"Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study","volume":"29","author":"Simpson","year":"2007","journal-title":"Clin Ther"},{"key":"10.1093\/bja\/aep253_bib61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0885-3924(97)00183-8","article-title":"Transdermal fentanyl as treatment for chronic low back pain","volume":"14","author":"Simpson","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aep253_bib62","first-page":"327","article-title":"Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain","volume":"5","author":"Slatkin","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1093\/bja\/aep253_bib63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/17425247.3.4.489","article-title":"Extended-release opioids for the management of chronic non-malignant pain","volume":"3","author":"Sloan","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1093\/bja\/aep253_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejpain.2004.06.001","article-title":"Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms","volume":"9","author":"Svendsen","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1093\/bja\/aep253_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(03)00047-2","article-title":"Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain","volume":"104","author":"Tassain","year":"2003","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1526-4637.2007.00298.x","article-title":"Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ)","volume":"8","author":"Taylor","year":"2007","journal-title":"Pain Med"},{"key":"10.1093\/bja\/aep253_bib67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2003-38651","article-title":"Fentanyl-TTS in the treatment of pain caused by arthrosis","volume":"141","author":"Theodoridis","year":"2003","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"10.1093\/bja\/aep253_bib68","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"10.1093\/bja\/aep253_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpainsymman.2006.07.011","article-title":"Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain","volume":"33","author":"Villars","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aep253_bib70","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"10.1093\/bja\/aep253_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0304-3959(00)00414-0","article-title":"Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID\u2019s: a randomised study comparing analgesia, antinociception and gastrointestinal effects","volume":"91","author":"Wilder-Smith","year":"2001","journal-title":"Pain"},{"key":"10.1093\/bja\/aep253_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1191\/026921601678576220","article-title":"Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice","volume":"15","author":"Zeppetella","year":"2001","journal-title":"Palliat Med"},{"key":"10.1093\/bja\/aep253_bib74","first-page":"CD004311","article-title":"Opioids for the management of breakthrough (episodic) pain in cancer patients","author":"Zeppetella","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aep253_bib75","first-page":"33","article-title":"Individual aspects of the quality of life of patients with chronic pain. Observational study of treatment with fentanyl-TTS","volume":"147","author":"Zimmermann","year":"2005","journal-title":"MMW Fortschr Med"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217339491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217339491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/103\/4\/576\/635347\/aep253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:45:52Z","timestamp":1757789152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217339491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0007091217339491"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aep253","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aep253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Author(s). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}